东阳光药(06887)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06887 东阳光药

未开盘 01-21 16:08:56

43.360

+0.960

+2.26%

最高43.500	最低41.380	成交量191.42万
今开42.840	昨收42.400	日振幅5.00%
总市值249.75亿	流通市值48.56亿	总股本5.76亿
成交额8,027万	换手率1.71%	流通股本1.12亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06887","market":"HK","secType":"STK","nameCN":"东阳光药","latestPrice":43.36,"timestamp":1768982936006,"preClose":42.4,"halted":0,"volume":1914247,"delay":0,"changeRate":0.022641509433962283,"floatShares":112000000,"shares":576000000,"eps":2.080908,"marketStatus":"未开盘","change":0.96,"latestTime":"01-21 16:08:56","open":42.84,"high":43.5,"low":41.38,"amount":80270648,"amplitude":0.05,"askPrice":43.36,"askSize":2300,"bidPrice":43.2,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.754,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769045400000},"marketStatusCode":0,"adr":0,"listingDate":1754496000000,"exchange":"SEHK","adjPreClose":42.4,"openAndCloseTimeList":[[1768959000000,1768968000000],[1768971600000,1768982400000]],"volumeRatio":8.936961009073089,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06887","defaultTab":"news","newsList":[{"id":"2605172656","title":"每日卖空追踪 | 东阳光药 01月21日卖空量成交4.3万股，卖空比例为2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605172656","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605172656?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984241,"startTime":"0","endTime":"0","summary":"东阳光药北京时间01月21日，涨2.26%，卖空量成交4.3万股，较上一交易日减少39.94%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165928a444d904&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165928a444d904&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2605173826","title":"东阳光药可威奥司他韦颗粒剂：专业化方案助力儿童流感防治","url":"https://stock-news.laohu8.com/highlight/detail?id=2605173826","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605173826?lang=zh_cn&edition=full","pubTime":"2026-01-21 13:50","pubTimestamp":1768974650,"startTime":"0","endTime":"0","summary":"东阳光药生产的可威磷酸奥司他韦颗粒剂，依托儿童专用剂型设计与本土化供应链能力，为1岁以上儿童提供从治疗到预防的一体化抗流感解决方案。02 防治结合：药物与疫苗协同防护可威奥司他韦颗粒剂适用于甲型与乙型流感的治疗与预防。可威奥司他韦颗粒剂的研发与生产，体现了儿童用药领域“剂量精准、操作便捷、供应稳定”的发展方向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://news.stockstar.com/IG2026012100019144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2605146733","title":"每日卖空追踪 | 东阳光药 01月20日卖空量成交2.98万股，卖空比例为11.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605146733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605146733?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:30","pubTimestamp":1768897838,"startTime":"0","endTime":"0","summary":"东阳光药北京时间01月20日，跌0.98%，卖空量成交2.98万股，较上一交易日增加0.68%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165541a4404cde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165541a4404cde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2604874184","title":"政策催化叠加价值兑现 国产创新药领域开启景气周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2604874184","media":"制药网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604874184?lang=zh_cn&edition=full","pubTime":"2026-01-19 13:44","pubTimestamp":1768801475,"startTime":"0","endTime":"0","summary":"多款国产新药密集获批、BD交易规模放量、海外临床进展提速，多重积极信号凸显行业高景气度，国产创新药正从研发驱动迈向价值兑现的关键阶段。根据数据统计，2026年开年以来，已有多款国产新药相继获批上市。进入2026年，国内创新药BD授权规模仍持续放量、合作模式升级。近年来，政策支持为行业发展保驾护航，叠加研发实力积累与商业化能力提升，国产创新药正迎来黄金发展时期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119134953a43b8e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119134953a43b8e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02105","06978","BK1574","01276","06887","09995"],"gpt_icon":0},{"id":"2604912573","title":"东阳光：与关联方共同增资合资公司用于收购秦淮数据中国100%股权暨关联交易交割完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2604912573","media":"蓝鲸财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604912573?lang=zh_cn&edition=full","pubTime":"2026-01-16 20:19","pubTimestamp":1768565990,"startTime":"0","endTime":"0","summary":"蓝鲸新闻1月16日电，东阳光(600673.SH)公告称，公司已合计向东数一号出资34.5亿元，履行完毕本次增资的出资义务。同时，东数三号已完成向卖方支付合计280亿元的交易价款（含代扣代缴税款）。本次交易涉及的交易价款已全部支付完毕，公司及交易各方已完成本次交易的交割工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116202120a722ff7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116202120a722ff7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2604912503","title":"每日卖空追踪 | 东阳光药 01月16日卖空量成交1.33万股，卖空比例为6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604912503","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604912503?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:30","pubTimestamp":1768552237,"startTime":"0","endTime":"0","summary":"东阳光药北京时间01月16日，涨0.98%，卖空量成交1.33万股，较上一交易日减少17.9%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116164150a4cb3e3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116164150a4cb3e3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2604912504","title":"东阳光药01月16日主力净流入41.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2604912504","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604912504?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:15","pubTimestamp":1768551336,"startTime":"0","endTime":"0","summary":"01月16日, 东阳光药股价涨0.98%，报收43.20元，成交金额910.8万元，换手率0.19%，振幅1.78%，量比1.07。东阳光药今日主力资金净流入41.6万元，上一交易日主力净流出148.5万元。该股近5个交易日下跌1.48%，主力资金累计净流出5.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1466.3万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116161845a7221719&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116161845a7221719&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2603595798","title":"东阳光药1类创新药奥洛格列净获批上市：控糖效果更优","url":"https://stock-news.laohu8.com/highlight/detail?id=2603595798","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603595798?lang=zh_cn&edition=full","pubTime":"2026-01-16 14:43","pubTimestamp":1768545788,"startTime":"0","endTime":"0","summary":"【东阳光药1类创新药奥洛格列净获批上市：控糖效果更优】近日，东阳光药自主研发的1类创新药奥洛格列净胶囊已获国家药监局批准上市，用于单药或联合二甲双胍改善成人2型糖尿病患者的血糖控制，为中国糖尿病患者提供了兼具精准疗效与综合获益的“中国创新”治疗方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/a/202601163621818948.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","06978","159992","BK1574","BK1191","06887"],"gpt_icon":0},{"id":"2603602658","title":"东莞控股：东阳光药在HECN30227Ⅰ期临床及小核酸平台研发等取得一定进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2603602658","media":"证券日报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603602658?lang=zh_cn&edition=full","pubTime":"2026-01-15 20:11","pubTimestamp":1768479061,"startTime":"0","endTime":"0","summary":"证券日报网讯1月15日，东莞控股在互动平台回答投资者提问时表示，东阳光药在HECN30227（靶向乙型肝炎病毒的siRNA药物）Ⅰ期临床及小核酸平台研发等取得一定进展，具体请查阅东阳光药发布的相关公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620626982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0234","BK0052","06887","BK0188","000828","BK0070","BK1191","BK0074","BK0118"],"gpt_icon":0},{"id":"2603672888","title":"东莞控股：金信资本投资了宏川智慧、东阳光药等公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2603672888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603672888?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:57","pubTimestamp":1768463831,"startTime":"0","endTime":"0","summary":"证券之星消息，东莞控股(000828)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问贵公司全资子公司金信资本投资了哪些公司？东莞控股回复：金信资本投资了宏川智慧、东阳光药等公司。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500020858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0205","BK0074","06887","BK0188","BK0234","BK0118","000828","BK0052","BK0070","002930","BK1191"],"gpt_icon":0},{"id":"2603157617","title":"港股公告掘金 | 东曜药业-B获药明合联溢价约99%提现金要约 1月15日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2603157617","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603157617?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:05","pubTimestamp":1768403110,"startTime":"0","endTime":"0","summary":"重大事项：龙旗科技(09611)1月14日至1月19日招股 拟全球发售5225.91万股H股和黄医药(00013)宣布SACHI III期研究结果于《柳叶刀 (The Lancet)》发表东阳光药(06887)推出面向PROTAC机制的AI智能研发平台 持续深化AI战略布局东曜药业-B(01875)获药明合联(02268)溢价约99%提现金要约 1月15日复牌维立志博-B(09887)：维利信(P","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00998","LU1720050803.USD","LU0051755006.USD","BK1161","BK1521","LU0210526637.USD","06887","BK1147","LU1522347837.USD","BK1191","LU1634259557.SGD","BK1516","LU0572940350.SGD","HK0000500386.USD","LU1497734951.SGD","01875","HK0000252160.HKD","LU0572939691.SGD","06030","LU1634259391.SGD","LU0456827905.SGD","LU2488822045.USD","LU0264606111.USD","BK1231","LU1794554557.SGD","02268","BK1141","BK1564","BK1574","SG9999014674.SGD","LU1497733557.USD","09887","BK1560","LU1497733631.SGD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2603439866","title":"每日卖空追踪 | 东阳光药 01月14日卖空量成交2.17万股，卖空比例为5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603439866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603439866?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:30","pubTimestamp":1768379438,"startTime":"0","endTime":"0","summary":"东阳光药北京时间01月14日，跌1.01%，卖空量成交2.17万股，较上一交易日减少3.12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164617a4c278cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164617a4c278cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2602399182","title":"两项三期临床研究取得积极结果，乙肝“功能性治愈”更近了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602399182","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602399182?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:07","pubTimestamp":1767877657,"startTime":"0","endTime":"0","summary":"实现乙肝功能性治愈的目标有了新的希望。当地时间1月7日，葛兰素史克对外宣布，公司与Ionis Pharmaceuticals合作开发的bepirovirsen，在治疗慢性乙型肝炎的两项关键性三期临床试验中取得积极结果。该药也有望成为全球首款获批的乙肝功能性治愈药物。国内也有部分药企在布局创新药研发，以推动乙肝的功能性治愈。未来，CB06有可能作为联合用药或与bepirovirsen进行序贯治疗，为更多乙肝患者提供功能性治愈的机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108210945a7033180&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108210945a7033180&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2602948399","title":"每日卖空追踪 | 东阳光药 01月08日卖空量成交3.26万股，卖空比例为25.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602948399","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602948399?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861039,"startTime":"0","endTime":"0","summary":"东阳光药北京时间01月08日，涨0.05%，卖空量成交3.26万股，较上一交易日减少58.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165117a4ab48ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165117a4ab48ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2602399976","title":"东阳光药01月08日主力净流入42.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2602399976","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602399976?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:15","pubTimestamp":1767860125,"startTime":"0","endTime":"0","summary":"01月08日, 东阳光药股价涨0.05%，报收43.02元，成交金额540.5万元，换手率0.11%，振幅2.98%，量比0.24。东阳光药今日主力资金净流入42.6万元，上一交易日主力净流出12.6万元。该股近5个交易日下跌5.66%，主力资金累计净流入971.8万元；近20日主力资金累计净流入2075.9万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108161910a7022046&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108161910a7022046&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"1121668363","title":"广东东阳光药业（06887）回购9,900股H股，总额约42.77万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121668363","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121668363?lang=zh_cn&edition=full","pubTime":"2026-01-06 18:45","pubTimestamp":1767696352,"startTime":"0","endTime":"0","summary":"广东东阳光药业股份有限公司于2026年1月6日发布翌日披露报表。公告显示，公司当日通过香港联交所回购9,900股H股，占回购前已发行股份总数的0.0088%，每股价格介乎42.38港元至44.32港元，涉资约427,734港元。本次变动后，公司已发行股份总数维持112,712,832股，其中112,089,032股为流通股，623,800股为库存股。公司确认本次回购已遵守香港联交所上市规则及相关法律法规，并提示本次回购后新股发行及任何库存股再出售的暂止期持续至2026年2月5日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887"],"gpt_icon":0},{"id":"2601853483","title":"21专访丨东阳光药首席科学家林凯：不盲目跟风 做更具创新性的事","url":"https://stock-news.laohu8.com/highlight/detail?id=2601853483","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601853483?lang=zh_cn&edition=full","pubTime":"2026-01-06 07:05","pubTimestamp":1767654309,"startTime":"0","endTime":"0","summary":"中国创新药行业正迎来从规模扩张向价值跃升的关键转折。当行业普遍面临赛道拥挤、同质化竞争的挑战时，本土药企该如何突破困局，实现高质量发展？近日，21世纪经济报道记者在东阳光科技园见到东阳光药首席科学家（CSO）林凯。他刚刚结束一场内部的项目会，一开始接受记者采访时略微紧张，但很快便放松下来。对于上述问题，林凯给出了清晰的答案：“不盲目跟风，做更具创新性的事情。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601063609294618.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601063609294618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","06887"],"gpt_icon":0},{"id":"2601332889","title":"东阳光药(06887)1月5日斥资389.83万港元回购8.88万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601332889","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601332889?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:37","pubTimestamp":1767616637,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东阳光药(06887)发布公告，于2026年1月5日该公司斥资389.83万港元回购8.88万股，回购价格为每股43.22-44.90港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"2601835998","title":"东阳光药(06887)：HECN30227已完成国内首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2601835998","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601835998?lang=zh_cn&edition=full","pubTime":"2026-01-05 19:16","pubTimestamp":1767611765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东阳光药 发布公告，HECN30227是集团自主研发并拥有全球知识产权的1类新药，可同时消除 cccDNA和intDNA来源的乙肝表面抗原。临床前数据表明，HECN30227具有泛基因型活性，可高效降低HBsAg水平，对核苷类药物耐药株同样保持突出药效，体内外药效亦优于临床竞品。截至目前，HECN30227已完成国内首例受试者入组。临床前重点品种包括：乙肝ASO：除了HECN30227，公司正同步开发“siRNA+ASO+免疫调节剂”三联疗法，通过多靶点协同作用全面抑制HBV和HBsAg。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06887","BK1191"],"gpt_icon":0},{"id":"1110696015","title":"廣東東陽光藥業（06887）12月股份变动月报：购回476,000股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1110696015","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110696015?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:56","pubTimestamp":1767603369,"startTime":"0","endTime":"0","summary":"廣東東陽光藥業股份有限公司于2026年1月5日公布截至2025年12月31日的股份变动月报。报告期内，公司注册股本维持人民币576,656,047元不变，其中H股注册股本112,712,832元及内资股注册股本463,943,215元均无增减。本月公司实施了H股的购回动作，购回数量为476,000股，价格为每股港币44.25。购回股份暂以库存股形式持有，致使期末H股已发行且在外流通的股份数为112,236,832股，库存股数为476,000股；内资股方面，本期未发生任何变化，期末维持463,943,215股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06887"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0132},{"period":"3month","weight":-0.0458},{"period":"6month","weight":-0.2802},{"period":"ytd","weight":-0.0491}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0304},{"period":"3month","weight":0.0238},{"period":"6month","weight":0.0471},{"period":"1year","weight":0.3222},{"period":"ytd","weight":0.0372}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广东东阳光药业股份有限公司是一家主要从事药物的研发、生产和商业化的中国公司。该公司专注于创新药，亦涉及改良型新药、仿制药和生物类似药。该公司的抗感染产品包括可威（磷酸奥司他韦），用于治疗流行性感冒（特别是甲型及乙型流行性感冒病毒），东卫恩（磷酸依米他韦），用于治疗丙型肝炎，及主要用于治疗敏感细菌引起的感染的仿制药，即克拉霉素、左氧氟沙星及盐酸莫西沙星。该公司的慢病治疗药物主要专注于治疗糖尿病、高尿酸血症、高血压及胃酸相关疾病，包括胰岛素产品及仿制药。该公司还关注肿瘤治疗领域。","exchange":"SEHK","name":"东阳光药","nameEN":"SUNSHINE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阳光药(06887)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光药(06887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光药,06887,东阳光药股票,东阳光药股票老虎,东阳光药股票老虎国际,东阳光药行情,东阳光药股票行情,东阳光药股价,东阳光药股市,东阳光药股票价格,东阳光药股票交易,东阳光药股票购买,东阳光药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光药(06887)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光药(06887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}